OK from what I can tell most if not all of the err

OK from what I can tell most if not all of the erroneous stuff has now been removed from the UNVC article. Also, they added info about Euromed. Here's the (revised) article as it exists now: If you see any additional errors please let them know. My job as an editorial supervisor for the author (Justin Kinney) living in his Mom's basement is now complete.

https://microcapdaily.com/bulls-take-charge-o...ment-70507

Quote:

---

Bulls Take Charge of Univec Conglomerate Inc. (OTCMKTS: UNVC) 6
BY JUSTIN KINNEY ON JULY 25, 2020MEDIA & TECHNOLOGY, MICRO CAP INSIDER, SMALL CAPS

Univec Conglomerate Inc. (OTCMKTS: UNVC) is one penny stock that has been rising steadily for years never giving back its gains and always moving on to new highs. From a start point in low triple zeros UNVC has skyrocketed over the years to recent highs of $0.0395. The stock has continued higher thanks to a low float and a tightly held stock structure thats not selling.

UNVC has attracted legions of shareholders over the years and has good liquidity built into it. The Company is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. Univec is currently working with Euromed to corner Europe’s medical MJ market and medicaid telemedicine and medicare in Aemerica.

Univec Conglomerate Inc. (OTCMKTS: UNVC) formerly Univec, Inc. (Univec), is an integrated licensing, manufacturing, and marketing company operating two divisions dedicated to providing safer health products to patients and caregivers worldwide. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide.

The Company is led by Dr David Dalton; a visionary who was named as one of the “Top 100 Healthcare Leaders” for 2019 by the International Forum on Advancements in Healthcare. With 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies including Mednet, ManagedcareRx, and Sivault Systems. Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom. Dr. Dalton received a Doctor of Pharmacy from West Virginia University School of Pharmacy. In addition to his extensive background in pharmaceutical field, he is a visiting professor and lectures at several schools of pharmacy throughout the United States, and former President of West Virginia University School of Pharmacy Presidential Committee. Dr Dalton has built an impressive BOD for UNVC including John C. Peoples, Past Vice President of Merck as welll as Kennnet Grant past Vice President of Johns Hopkins Health System.

To Find out the inside Scoop on UNVC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below


UNVC

Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 reporting at the time: “UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock has quickly attracted a large shareholder base which has been bidding this one higher. Currently trading at a $7.5 million market valuation according to OTCMarketsgroup it looks as if there is a lot going on behind the scenes at Univec.”

We have a Monster Pick Coming. Subscribe Right Now!

Currently moving steadily higher it looks as if there is a lot going on behind the scenes at Univec. UNVC is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. The Company is currently working with Euromed to corner Europe’s medical MJ market and medicaid telemedicine and medicare in Aemerica. Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005. We will be updating on UNVC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with UNVC.

---